ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Immunohistochemical analysis of Ki-67, p53 and Bcl-2 expression related to histological features in gastroesophageal reflux disease
(Turk J Gastroenterol 2010; 21: 199-205)
DOI: 10.4318/tjg.2010.0088
Utility of esophageal manometry and pH-metry in gastroesophageal reflux disease before surgery
(Turk J Gastroenterol 2009; 20: 261-265)
DOI: 10.4318/tjg.2009.0023
Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
(Turk J Gastroenterol 2008; 19: 146-151)
Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community
(Turk J Gastroenterol 2007; 18: 14-19)
Does acid reflux cause pulmonary disease?
(Turk J Gastroenterol 2005; 16: 199-202)
Characteristics of gastroesophageal reflux disease in our country
(Turk J Gastroenterol 1999; 10: 101-106)
Does omeprazole alter the salivary gland functions?
(Turk J Gastroenterol 2001; 12: 113-116)
Hypersensitive esophagus: can it be classified as a subgroup of gastroesophageal reflux disease?
(Turk J Gastroenterol 2002; 13: 24-30)
Review
How is gastroesophageal reflux disease classified?
(Turk J Gastroenterol 2017; 28: 10-11)
DOI: 10.5152/tjg.2017.04
To whom and when the upper gastrointestinal endoscopy is indicated in gastroesophageal reflux disease? What is the role of routine esophageal biopsy? Which endoscopic esophagitis classification should be used?
(Turk J Gastroenterol 2017; 28: 22-25)
DOI: 10.5152/tjg.2017.07
How should we describe, diagnose and observe the Barrett's esophagus?
(Turk J Gastroenterol 2017; 28: 26-30)
DOI: 10.5152/tjg.2017.08
Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
(Turk J Gastroenterol 2017; 28: 31-32)
DOI: 10.5152/tjg.2017.09
Which drugs are risk factors for the development of gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 38-43)
DOI: 10.5152/tjg.2017.11
Which diseases are risk factors for developing gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 44-47)
DOI: 10.5152/tjg.2017.12
What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
(Turk J Gastroenterol 2017; 28: 57-60)
DOI: 10.5152/tjg.2017.15
Gastroesophageal reflux disease and the relationship with Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 61-67)
DOI: 10.5152/tjg.2017.16
When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?
(Turk J Gastroenterol 2017; 28: 68-70)
DOI: 10.5152/tjg.2017.17
What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
(Turk J Gastroenterol 2017; 28: 71-72)
DOI: 10.5152/tjg.2017.18
Original Article
A functional study of the esophagus in patients with non-cardiac chest pain and dysphagia
(Turk J Gastroenterol 2015; 26: 99-103)
DOI: 10.5152/tjg.2015.5865
Is gastroesophageal reflux contribute to the development chronic cough by triggering pulmonary fibrosis
(Turk J Gastroenterol 2014; 25: 48-53)
DOI: 10.5152/tjg.2014.4018
Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux
(Turk J Gastroenterol 2015; 26: 367-372)
DOI: 10.5152/tjg.2015.0110
Non-erosive reflux disease compared with erosive esophagitis with regards to acid reflux and symptom patterns
(Turk J Gastroenterol 2011; 22: 464-471)
DOI: 10.4318/tjg.2011.0249
What is the diagnostic utility of endoscopic scoring systems in children?
(Turk J Gastroenterol 2013; 24: 22-29)
DOI: 10.4318/tjg.2013.0700
Gastroesophageal reflux disease prevalence in the city of Sivas
(Turk J Gastroenterol 2013; 24: 303-310)
DOI: 10.4318/tjg.2013.0256
In vitro effects of famotidine and ranitidine on lower esophageal sphincter tone in rats
(Turk J Gastroenterol 2012; 23: 438-443)
DOI: 10.4318/tjg.2012.0448
Ineffective esophageal motility and gastroesophageal reflux disease: A close relationship?
(Turk J Gastroenterol 2012; 23: 627-633)
DOI: 10.4318/tjg.2012.0452
Gastroesophageal reflux in children with functional constipation
(Turk J Gastroenterol 2012; 23: 634-638)
DOI: 10.4318/tjg.2012.0454
The effect of narrowed segment length on the degree of early postoperative dysphagia in laparoscopic Nissen fundoplication
(Turk J Gastroenterol 2012; 23: 676-680)
DOI: 10.4318/tjg.2012.0487
Typical symptoms rather than extraesophageal symptoms affect the quality of life in gastroesophageal reflux disease
(Turk J Gastroenterol 2012; 23: 747-752)
DOI: 10.4318/tjg.2012.0480
Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: A population-based cross-sectional study
(Turk J Gastroenterol 2012; 23: 323-332)
DOI: 10.4318/tjg.2012.0352
Benign glycogenic acanthosis lesions of the esophagus
(Turk J Gastroenterol 2012; 23: 199-202)
DOI: 10.4318/tjg.2012.0501
Clinical characteristics and natural history of asymptomatic erosive esophagitis
(Turk J Gastroenterol 2014; 25: 248-252)
DOI: 10.5152/tjg.2014.5033
Atrial fibrillation and sympathovagal balance in patients with gastroesophageal reflux disease
(Turk J Gastroenterol 2017; 28: 88-93)
DOI: 10.5152/tjg.2017.16540
Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer
(Turk J Gastroenterol 2016; 27: 227-232)
DOI: 10.5152/tjg.2016.15375
Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study
(Turk J Gastroenterol 2017; 28: 104-109)
DOI: 10.5152/tjg.2016.0284
The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia
(Turk J Gastroenterol 2016; 27: 73-80)
DOI: 10.5152/tjg.2015.150238
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 30.11.2017